These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 19825325)

  • 1. Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
    Becher H; Kostev K; Schröder-Bernhardi D
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):617-26. PubMed ID: 19825325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic characteristics and representativeness of the German Disease Analyzer database
.
    Rathmann W; Bongaerts B; Carius HJ; Kruppert S; Kostev K
    Int J Clin Pharmacol Ther; 2018 Oct; 56(10):459-466. PubMed ID: 30168417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges.
    Visser ST; Schuiling-Veninga CC; Bos JH; de Jong-van den Berg LT; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):285-92. PubMed ID: 23763527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoepidemiological research using French reimbursement databases: yes we can!
    Martin-Latry K; Bégaud B
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):256-65. PubMed ID: 20128015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.
    Ohlmeier C; Langner I; Hillebrand K; Schmedt N; Mikolajczyk R; Riedel O; Garbe E
    BMC Public Health; 2015 Jun; 15():570. PubMed ID: 26087768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label use of proton pump inhibitors and P-blockers in general practices: an analysis using the Disease Analyzer--mediplus patient database.
    Schröder-Bernhardi D; Roth K; Dietlein G
    Int J Clin Pharmacol Ther; 2004 Nov; 42(11):581-8. PubMed ID: 15598023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the mediplus patient database in healthcare research.
    Dietlein G; Schröder-Bernhardi D
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):130-3. PubMed ID: 11911603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nordic countries as a cohort for pharmacoepidemiological research.
    Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
    Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide variation in the number of different drugs prescribed by general practitioners. A prescription database study.
    Bjerrum L; Bergman U
    Scand J Prim Health Care; 2000 Jun; 18(2):94-8. PubMed ID: 10944063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations.
    Pigeot I; Ahrens W
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):215-23. PubMed ID: 18200610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of physicians' participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study in Germany.
    Koch C; Schleeff J; Techen F; Wollschläger D; Schott G; Kölbel R; Lieb K
    PLoS Med; 2020 Jun; 17(6):e1003151. PubMed ID: 32589633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
    Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
    Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long-term opioid therapy for chronic pain?
    Richarz U; Jacobs A; Spina E
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):453-62. PubMed ID: 22081534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug prescription in pregnancy: analysis of a large statutory sickness fund population.
    Egen-Lappe V; Hasford J
    Eur J Clin Pharmacol; 2004 Nov; 60(9):659-66. PubMed ID: 15480609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaco-epidemiologic study of the prescription of contraindicated drugs in a primary care setting of a university: a retrospective review of drug prescription.
    Dhabali AA; Awang R; Zyoud SH
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):500-9. PubMed ID: 21781650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic dispensing rates for substitutable drugs prescribed by general practitioners compared with other private ambulatory specialists: A study based on a French national reimbursement database.
    Figoni H; Robert S; Bonello K; Ibanez G; Chastang J; Estellat C
    Eur J Gen Pract; 2024 Dec; 30(1):2407600. PubMed ID: 39397787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of pain medication prescriptions in France, Germany, and the UK - a cross-sectional study including 4,270,142 patients.
    Jacob L; Kostev K
    Postgrad Med; 2018 Jan; 130(1):32-36. PubMed ID: 29022417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completeness of prescription information in US commercial claims databases.
    Lauffenburger JC; Balasubramanian A; Farley JF; Critchlow CW; O'Malley CD; Roth MT; Pate V; Brookhart MA
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):899-906. PubMed ID: 23696101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.